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Abstract
Background: Senecavirus A (SVA), a member of the family Picornaviridae, genus Senecavirus, is a recently identified
single-stranded RNA virus closely related to members of the Cardiovirus genus. SVA was originally identified as a cell
culture contaminant and was not associated with disease until 2007 when it was first observed in pigs with
Idiopathic Vesicular Disease (IVD). Vesicular disease is sporadically observed in swine, is not debilitating, but is
significant due to its resemblance to foreign animal diseases, such as foot-and-mouth disease (FMD), whose
presence would be economically devastating to the United States. IVD disrupts swine production until foreign
animal diseases can be ruled out. Identification and characterization of SVA as a cause of IVD will help to quickly
rule out infection by foreign animal diseases.
Methods: We have developed and characterized an indirect ELISA assay to specifically identify serum antibodies to
SVA. Viral protein 1, 2 and 3 (VP1, VP2, VP3) were expressed, isolated, and purified from E. coli and used to coat
plates for an indirect ELISA. Sera from pigs with and without IVD symptoms as well as a time course following
animals from an infected farm, were analyzed to determine the antibody responses to VP1, VP2, and VP3.
Results: Antibody responses to VP2 were higher than VP1 and VP3 and showed high affinity binding on an avidity
ELISA. ROC analysis of the SVA VP2 ELISA showed a sensitivity of 94.2% and a specificity of 89.7%. Compared to IFA,
the quantitative ELISA showed an 89% agreement in negative samples and positive samples from 4–60 days after
appearance of clinical signs. Immune sera positive for FMDV, encephalomyocarditis virus, and porcine epidemic
diarrhea virus antibodies did not cross-react.
Conclusions: A simple ELISA based on detection of antibodies to SVA VP2 will help to differentially diagnose IVD
due to SVA and rule out the presence of economically devastating foreign animal diseases.
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Background
Senecavirus A (SVA), a member of the family Picornavir-
idae, genus Senecavirus, is a recently identified single-
stranded RNA virus closely related to members of the
Cardiovirus genus [1, 2]. SVA was originally identified as a
cell culture contaminant and was not associated with dis-
ease until 2007 when it was first observed in pigs with
Idiopathic Vesicular Disease (IVD) [2, 3]. Vesicular disease
is sporadically observed in swine, is not debilitating, but is
significant due to its resemblance to foreign animal dis-
eases, such as foot-and-mouth disease (FMD), whose pres-
ence would be economically devastating to the United
States [3, 4]. IVD disrupts swine production until foreign
animal diseases can be ruled out. Identification and
characterization of SVA as a cause of IVD will help to
quickly rule out infection by foreign animal vesicular dis-
ease pathogens.
IVD in association with SVA has been observed recently
in Canada, the United States, and Brazil, in the absence of
other vesicular foreign animal diseases [3, 5, 6]. A quick
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test to diagnose SVA infection is necessary to help rule
out infection by foreign animal diseases without pro-
longed disruption of animal movement. As of now, SVA
infection is diagnosed by RT-PCR, a serum neutralizing
assay, indirect fluorescent antibody test (IFA), or competi-
tive enzyme-linked immunosorbent assay (cELISA) [6–9].
RT-PCR is a rapid method to determine if animals are
acutely infected with virus or if vesicles contain virus, but
a negative result cannot be used to rule out previous herd
exposure since clinical signs of infection are usually re-
solved within 1–2 weeks [6, 10]. Presence of antibodies to
SVA may indicate previous infection and possible pres-
ence of the virus in a herd. Although serum neutralization
and IFA test for the presence of serum antibodies, ELISA
is more rapid and convenient. A rapid, specific and sensi-
tive assay for the detection of SVA-specific antibodies is
needed. A cELISA for the detection of SVA antibodies is
available, but requires an antibody competition between
well characterized monoclonal antibodies and serum
antibodies for binding to inactivated viral antigen [7].
An indirect ELISA only requires a purified antigen and so
is not susceptible to mutations that change reactivity of
the monoclonal antibody-binding epitope. An SVA VP1
ELISA has recently been used to examine antibody pres-
ence in sows and piglets naturally infected with SVA, how-
ever a comprehensive validation of this assay was not
shown [11]. Although numerous ELISA kits used for the
detection of viral antibodies are commercially available, an
indirect ELISA kit is not yet commercially available for the
detection of anti-SVA antibodies in pigs.
An optimized, well characterized, quick and inexpensive
indirect ELISA for the detection of SVA antibodies as well
as a thorough examination of antibodies and their levels
over a time course following infection is needed. The aim
of this study was to develop and characterize an indirect
ELISA assay to identify serum antibodies to SVA as well
as examine the kinetics of the presence and levels of SVA
antibodies over a time course following infection. The
SVA VP2 ELISA developed in this study can now be used
to help differentially diagnose IVD due to SVA, helping to
quickly rule out the presence of an economically devastat-
ing foreign animal disease.
Methods
Cloning, expression and purification of SVA VP1, VP2, and
VP3 protein
The full length gene sequences for SVA VP1, VP2, and
VP3 from strain 11-55910-3 (Genbank ID AGM16001)
was optimized for expression in E. coli, synthesized
(Integrated DNA Technologies, Inc., Coralville, IA), and
cloned into a modified pET24b vector (Novagen, Madison,
WI) [12] using the In-Fusion cloning kit (Clontech,
Mountain View, CA) following the manufacturer’s direc-
tions. Gene sequences for VP1, VP2, and VP3 antigens
were confirmed by sequencing. Protein expression and
purification was performed as previously described
[13]. Purity was analyzed by SDS-PAGE, stained using
Imperial™ protein stain (ThermoFisher Scientific, Waltham,
MA). Protein concentrations used to establish plate coating
conditions were determined using the Quick-start Bradford
protein assay following manufacturer’s instructions
(Bio-Rad Laboratories, Inc., Hercules, CA) using a
Bio-tek Epoch plate reader (BioTek Instruments, Inc.,
Winooski, VT).
Serum samples
Recent and archived porcine serum samples that had been
previously submitted to the University of Minnesota
Veterinary Diagnostic Laboratory (UMN-VDL) for routine
diagnostics or specific viral pathogen evaluation were ob-
tained. The samples were provided for diagnostic pur-
poses, not specifically for use in this study. In addition,
positive serum samples were obtained from 34 sows clin-
ically diagnosed with vesicular lesions and bled periodic-
ally over a 60-day period starting at the first observation
of clinical signs (sampling at day 0, 4, 11,18, 25, 39, and
60) (n = 205). Serum samples that tested negative for SVA
by PCR (n = 116) were obtained from sows and finishing
pigs from various farms with no prior evidence of vesicu-
lar disease. These animals were assumed to be SVA
antibody-negative and were treated as such in this study.
Porcine epidemic diarrhea virus (PEDV) seropositive sam-
ples (n = 40) were archived samples from our laboratory
and encephalomyocarditis virus (EMCV) seropositive
samples were obtained from the UMN-VDL (n = 8). FMD
seropositive samples (n = 21) were archived samples from
Plum Island Animal Disease Center representing 8 differ-
ent serotypes, 2 field samples, and ranged from 0 to 36
days post-infection/post-challenge. The FMDV samples
were examined for cross-reactivity against the SVA VP1,
VP2, and VP3 ELISA at Plum Island Animal Disease Cen-
ter (PIADC) facilities following the ELISA protocol de-
scribed here.
Antibody detection by ELISA and IFA
Detection of antibodies to SVA VP1, VP2, and VP3 pro-
tein was performed by indirect ELISA as previously de-
scribed [12, 13] on microtiter plates coated with either
500 ng or 200 ng of antigen per well or a combination
of all 3 proteins at 100 ng each (300 ng total protein per
well). Positive and negative control serum samples were
run on each plate.
An avidity ELISA was performed following the ELISA
protocol above, coating with 200 ng of VP2 antigen per
well, and with the addition of a guanidine HCl wash
step. Before secondary antibody was added, 1 M guan-
idine HCl in phosphate buffered saline (PBS) + 0.05%
Tween-20, pH 7.4, was added to each well and incubated
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for 10 min. Plates were then washed as usual, secondary
antibody was added, and the remainder of the ELISA
protocol was performed as above. The avidity index was
determined by dividing the optical density (OD) of the
sample treated with guanidine by the OD of the sample
without guanidine treatment (ODGn+/ODGn-).
The UMN-VDL performed a diagnostic IFA test to
detect anti-SVA antibodies present in serum. Briefly,
human lung cancer NCI-H1299 cells were inoculated
with an SVA strain isolated in 2015 from an outbreak in
the U.S. Infected cells were washed with PBS, fixed with
acetone and incubated using two-fold dilutions of serum
from 1:20 to 1:320 at 37 °C for 1 h. After fluorescein la-
beled goat anti-pig IgG diluted 1:50 in PBS was added
into the wells and incubated at 37 °C for 1 h, the cells
were observed under fluorescence microscopy. A posi-
tive signal at a sample dilution of 1:20 was considered
suspect and a 1:40 or higher dilution was considered to
be positive.
Statistical methods
ELISA analysis, receiver-operator characteristics (ROC)
analysis, and comparison to the IFA results were per-
formed using GraphPad Prism software (Version 5.0a,
GraphPad Software, Inc., La Jolla, CA).
Results
SVA protein expression and ELISA development
The SVA VP1, VP2, and VP3 proteins were cloned,
expressed, and purified. Protein preparations were ob-
served to be >90% pure (Fig. 1). ELISA plates were
coated with 500 ng/well of VP1, VP2 or VP3 protein and
samples were examined for anti-SVA antibody reactivity.
SVA-negative samples from a neighboring farm (n = 28)
were used to determine the cut-off values for negative
(<ODavg + 1SD) and positive (>ODavg + 2SD) samples.
Suspect positive samples occurred if the OD value fell
between the negative and positive sample cut-off values.
The SVA ELISA was first evaluated using samples
from a farm showing clinical signs, starting at the day
clinical signs were first observed (Day 0) and sampled
up to 60 days post-break (Days 4, 11, 18, 25, 39, 60).
Comparison of antibody reactivity to VP1, VP2, or VP3
showed that VP2 was significantly different than VP1
and VP3 (p < 0.0001) giving the largest range of OD
values and the biggest difference between positive and
negative sample values (Fig. 2). VP1 showed some
negative values at all time points and lower values
overall, while VP3 showed limited immunoreactivity
and discriminated poorly between positive and nega-
tive. A coating combination of 100 ng each of VP1,
VP2, and VP3 together on the same samples shown
in Fig. 2 gave results that were correlated with VP2
antigen alone (r2 = 0.927, p < 0.0001).
SVA VP2 ELISA optimization and validation
Further optimization of VP2 ELISA sensitivity and speci-
ficity led to coating plates with 200 ng VP2 protein per
well. ROC analysis was performed using 116 negative
samples and 205 positive samples. At a positive/negative
sample cut-off value of OD = 0.6, the area under the
curve to differentiate positive from negative was 0.9622
with a p value <0.0001. Test sensitivity was 94.2% and
specificity was 89.7%.
Cross-reactivity of the SVA VP2 ELISA was evaluated
by testing samples that were seropositive for PEDV, a
coronavirus, EMCV, a closely related picornavirus, and
FMDV, a high-consequence animal picornavirus patho-
gen that causes vesicular lesions. We observed that 3%
of PEDV-positive serum samples in a herd with no his-
tory of SVA exposure tested positive (ODavg = 0.081,
SD = 0.119) (Fig. 3). All EMCV seropositive samples were
negative for SVA antibodies (ODavg = 0.085, SD = 0.040)
(Fig. 3). FMD seropositive samples were examined for
cross-reactivity on the VP1, VP2, and VP3 ELISAs. The
FMDV ELISA was run at PIADC and the absorbance
values (including positives and negatives) were lower than
when the ELISA tests were run in our laboratory. Thus
the cut-off values were adjusted based on the OD values
of the positive and negative controls (Fig. 3). In the VP1
ELISA, 1 of the positive control samples was identified as
suspect instead of positive and the VP3 ELISA identified 2
positive control samples as negative and 1 as suspect. For
the FMDV-seropositive samples, 2 were identified as SVA
VP1 positive and 4 as suspect, and no samples were
positive for the VP3 ELISA. On the VP2 ELISA, 20 of
the 21 (95.3%) samples tested negative and one (4.7%)
sample tested positive. The FMDV positive sample that
Fig. 1 SVA VP1, VP2, and VP3 purified proteins. Purity of the proteins
eluted from cobalt affinity columns were visualized by SDS-PAGE.
Molecular weights are determined by comparison to kaleidoscope
pre-stained standards (Bio-rad, Hercules, CA) run on the same gel
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cross-reacted on the SVA VP2 ELISA was serotype A24.
Notably, this sample also reacted with SVA VP1, suggest-
ing that it was a true positive reaction and not cross-
reactivity, since antibodies reacted against 2 SVA antigens.
Avidity ELISA confirmation of reactivity
Avidity, or functional affinity, measures the strength of a
polyclonal antibody interaction with antigen, based on
reduction in ELISA reactivity caused by incubation of the
antigen-antibody complex with a denaturing agent.
Figure 4 shows that the avidity index increased until
25 days after clinical signs were first observed. In addition,
the proportion of samples with an avidity index >0.5 was
greater than 80% at all times after 25 days (Fig. 4).
The avidity ELISA was also used to evaluate non-
specific antibody reactivity against SVA VP2 protein that
would give rise to false positive interpretations. The PEDV
seropositive samples that cross-reacted with the SVA VP2
ELISA were evaluated by the avidity ELISA. These sam-
ples were clearly negative using the avidity ELISA (avidity
index = 0.04). By contrast, the lowest avidity index in SVA
seropositive samples from infected herds was 0.12 on the
day clinical signs were first observed and the average avid-
ity index of SVA seropositive samples was 0.52.
Comparison of ELISA to IFA
Comparison of negative samples and positive samples
from the infection time course showed that ELISA and
IFA were correlated (n = 231, p < 0.0001) (Fig. 5). The
IFA has a specificity of 100% and a sensitivity of 90.3%.
Agreement on negative samples was 89% and agreement
from 4 to 60 days after appearance of clinical signs var-
ied from 73 to 100%. However, on the day that clinical
signs were first observed (Day 0), test agreement was




















































Fig. 2 Time course of antibody responses to SVA VP1, VP2, and VP3. Serum samples collected from sows at the onset of clinical signs until
60 days later were tested in duplicate wells coated with 500 ng of each antigen. Negative control serum (Neg) was from a matched SVA-negative
farm. Results are shown as a box whisker plot using the Tukey method for outliers for (a) VP1, (b) VP2, and (c) VP3 proteins. The suspect positive

















Fig. 3 Cross-reactivity analysis of SVA VP2 ELISA to other virus
seropositive samples. The SVA VP2 ELISA was performed on pig samples
that were seropositive to other viruses (FMDV, EMCV, or PEDV), but
whose SVA antibody status was unknown. The positive/negative cut-off
values for EMCV and PEDV tested at the University of Minnesota, and
FMDV tested at PIADC are shown by the dashed line
Fig. 4 Avidity analysis on VP2 ELISA positive samples. The average
avidity index (AI, black line) and percent of samples with low (<0.5, light
grey bar) or high (>0.5, dark grey bar) AI are shown at each time point
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40%, which was due to samples testing ELISA positive,
but IFA negative or suspect (Fig. 5). In cases of disagree-
ment, ELISA was usually positive while IFA was negative
or suspect. Three percent of total samples were ELISA
negative, but IFA positive (days 11, 18, and 60).
Discussion
Rapid diagnostic methods to test for SVA exposure in
cases of vesicular disease are critical to the U.S. swine
industry since animal movement, an essential aspect of
modern swine production, can be halted if foot-and-
mouth disease virus (FMDV) infection is suspected. The
incidence of SVA has greatly increased since mid-2015,
creating a compelling need for a simple, high-throughput
test [10]. We have developed a sensitive and specific
SVA ELISA for the detection and diagnosis of SVA-
specific antibodies.
Surprisingly, VP2 antigen was substantially more im-
munogenic than VP1 and VP3 in the population as a
whole, although occasional pigs were observed with high
antibody levels to one or both of VP1 and VP3, as
shown in Fig. 2. The sensitivity and specificity of the
VP2 ELISA, 94.2 and 89.7%, respectively, indicate that it
would be a reliable test to identify infected herds. The
VP1 protein in picornaviruses is the most external and
immunodominant [14] and has been used for numerous
ELISA assays to detect picornavirus antibodies. However,
many of the monoclonal antibody epitopes have been
identified in VP2 and, because VP2 is more conserved
than VP1, VP2 may be better able to detect across sero-
types [15, 16]. Even though VP2 is conserved, cross-
reactivity of the SVA VP2 ELISA to immune serum of
the closely related picornavirus, EMCV, was not ob-
served. Reactivity was observed in one (4.7%) FMDV
seropositive sample. Since this serum sample, alone
among 21 in total, also reacted with VP1, the most likely
explanation is that the source animal was cryptically in-
fected with SVA. The pig had been obtained from a
commercial supplier and did not show clinical symp-
toms of disease, but its prior history was not known.
An avidity ELISA assesses the strength of antibody
binding to antigen, thus denaturing weak interactions
that are a common source of cross-reactivity and back-
ground noise [17]. Its use helps to increase assay specifi-
city and to confirm suspect samples as positive or
negative. In addition, an increase in avidity of the time
course of an immune response can be used to monitor B
lymphocyte maturation and antibody affinity increase
that occurs during isotype switching and hypersomatic
mutation in light and heavy chains [18]. We observed
that the avidity index was low until about 3 weeks post-
clinical signs, thus indicating that the humoral response
was in an early stage and that infection was recent. It
suggests that the avidity ELISA may be a useful indicator
of outbreak initiation. Comparison of ELISA and IFA
showed that ELISA also was more sensitive in diagnos-
ing early infection. At later times (day 4–11 and later),
ELISA and IFA were both able to identify SVA positive
animals at similar rates, as shown in Fig. 5. Identification
of SVA antibody-positive animals by SVA VP2 ELISA
along with either the avidity ELISA or IFA as a con-
firmatory test in case of suspected false negatives, may
be ideal for the immuno-diagnosis of SVA infection.
The kinetics of the antibody response to SVA have
been recently examined. In a naturally infected farm
ELISA-positive antibodies (anti-SVA VP1) were observed
in pig serum at 1 week post-clinical signs in less than
15% of animals [11]. However, at 3 weeks post-clinical
signs over 70% of animals were seropositive and by
6 weeks over 90% of animals were seropositive [11]. Ex-
perimental SVA infection of 9 week old pigs showed that
all animals seroconverted by 15 days post-infection as
determined by an indirect fluorescent antibody test [10].
In this study, we observed that SVA VP2 antibodies were
present in 84% of animals when clinical signs were first
observed and persisted for 60 days after clinical signs
were first observed, though they were in decline from
peak levels observed on day 11. In experimental infec-
tion of 9 week old pigs, vesicular lesions were first ob-
served on the feet at 4 days, and nearly all pigs showed
lesions at 5 days [10]. Since antibodies typically are not
detected until 7 to 10 days after antigen exposure, it sug-
gests that antibodies would not be present on the day
clinical signs were first observed, as was observed by
SVA IFA (only 24% of animals are seropositive by IFA
on day 0) and by SVA VP1 ELISA, which was even less
sensitive [11]. By contrast, the SVA VP2 ELISA is more
sensitive, detecting antibodies in 84% of animals on the
day of clinical signs.
Fig. 5 VP2 ELISA and IFA comparison. The percent of VP2 ELISA
positive (closed circles) samples and the percent of IFA positive
(open squares) and IFA suspect (closed squares) samples are shown
over a 60 day time course
Dvorak et al. BMC Veterinary Research  (2017) 13:50 Page 5 of 6
Conclusions
An indirect ELISA based on SVA VP2 can rapidly and
reliably detect SVA antibodies present in swine. Identifi-
cation of SVA infection as the cause of IVD can help to
quickly rule out the presence of economically devastat-
ing foreign animal diseases in swine, enable producers to
return to normal production after clinical signs have re-
solved, and make informed management decisions.
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